The global in vitro fertilization market size reached USD 26.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 50.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.27% during 2025-2033. The market growth is primarily driven by the rapid integration of genetic screening technologies such as PGT, the growing popularity of fertility preservation methods, and the increasing focus on customized fertility treatments tailored to individual patient needs for enhanced outcomes.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 26.2 Billion |
Market Forecast in 2033 | USD 50.9 Billion |
Market Growth Rate (2025-2033) | 7.27% |
Growing Integration of Genetic Screening Technologies
A prominent trend in the industry is the rapid integration of genetic screening technologies, such as preimplantation genetic testing (PGT). These technologies are increasingly being used to assess embryos for genetic disorders before implantation, leading to higher success rates and reducing the chances of miscarriage. This trend is particularly beneficial for couples with a history of genetic diseases or those undergoing IVF treatments at an advanced maternal age. The demand for PGT is further driven by the increased awareness of the role genetics play in reproductive health, along with continual advancements in genetic testing technology, are making these procedures more accurate and accessible. As genetic screening continues to shift, it is expected to play an even more significant role in improving outcomes globally and impelling the market.
Rising Popularity of Fertility Preservation Techniques
Another key trend in the in vitro fertilization market growth is the rising popularity of fertility preservation techniques, particularly egg freezing. Increasingly, individuals are delaying parenthood due to career, financial, or personal reasons, thereby driving demand for proactive fertility options such as egg and embryo freezing. This trend is supported by ongoing advancements in cryopreservation technologies, enhancing the success rates of thawed eggs and embryos. According to a study published by Oxford Press, live birth rates (LBRs) following embryo and oocyte cryopreservation are 41% and 32%, respectively. For IVF and spontaneous LBRs after tissue cryopreservation and transplantation, the rates are 21% and 33%. Moreover, growing awareness and availability of fertility preservation services for cancer patients undergoing treatments that may affect fertility is further fueling this trend, establishing it as a critical aspect of the shifting market landscape.
Growing Emphasis on Personalized Fertility Treatments
With advancements in medical technologies and a deeper understanding of individual reproductive health, fertility clinics are moving towards customized treatment plans tailored to the specific needs of each patient. Personalized IVF protocols consider factors such as hormonal profiles, genetic predispositions, and underlying health conditions, aiming to optimize success rates by minimizing risks and enhancing embryo quality. This shift towards individualized care is particularly important for patients who may have undergone multiple failed IVF cycles, as it offers a more targeted approach. As the demand for tailored medical solutions grows, personalized fertility treatments are expected to gain further traction, offering more effective and patient-centered care in the in vitro fertilization market share.
IMARC Group provides an analysis of the key trends in each segment of the global in vitro fertilization market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, procedure type, cycle type and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the in vitro fertilization market based on the product. This includes reagent (cryopreservation media, embryo culture media, ovum processing media, and sperm processing media), instrument (imaging systems, incubators, cryosystems, IVF cabinet, ovum aspiration pump, sperm separation systems, micromanipulator systems and others), and accessories. According to the report, instrument represented the largest segment.
Procedure Type Insights:
A detailed breakup and analysis of the in vitro fertilization market based on the procedure type has also been provided in the report. This includes fresh donor, frozen donor, fresh non-donor, and frozen non-donor. According to the report, frozen non-donor accounted for the largest market share.
Cycle Type Insights:
The report has provided a detailed breakup and analysis of the in vitro fertilization market based on the cycle type. This includes conventional IVF, IVF with ICSI, and IVF with donor eggs. According to the report, IVF with ICSI represented the largest segment.
End User Insights:
A detailed breakup and analysis of the in vitro fertilization market based on the end user has also been provided in the report. This includes fertility clinics, hospitals, and others. According to the report, fertility clinics accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific was the largest market for in vitro fertilization. Some of the factors driving the Asia-Pacific in vitro fertilization market growth include the increasing awareness and acceptance of IVF, rising incidences of medical conditions, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global in vitro fertilization market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered |
|
Procedure Types Covered | Fresh Donor, Frozen Donor, Fresh Non-donor, Frozen Non-donor |
Cycle Types Covered | Conventional IVF , IVF with ICSI, IVF with Donor Eggs |
End Users Covered | Fertility Clinics, Hospitals, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Boston IVF, CooperSurgical Inc. (The Cooper Companies Inc.), Esco Micro Pte. Ltd, FUJIFILM Holdings Corporation, Genea Pty Limited, Hamilton Thorne Ltd., SAFE Fertility Center, Vitrolife AB, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |